Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Exploring RNA interference as a therapeutic strategy for renal disease

Abstract

The short synthetic interfering RNA duplexes (siRNAs) can selectively suppress gene expression in somatic mammalian cells without nonselective toxic effects of double-stranded RNA (dsRNA). However, a selective in vivo delivery of siRNA transfer has not been reported in kidney. Here, we investigated whether injection of synthetic siRNAs via renal artery followed by electroporation could be effective and therapeutic in silencing specific gene in glomerulus. We investigated the effect of siRNA in rat cultured mesangial cells (MCs) and showed that siRNA sequence-specific suppression of transgene expression was over a 1000-fold more potent than that by antisense oligodeoxynucleotide (ASODN). Transfection of siRNA targeting luciferase into rat kidneys significantly inhibited expression of a cotransfected luciferase expression vector in vivo. The delivery of siRNA targeting enhanced green fluorescent protein (EGFP) in the transgenic ‘green’ rat reduced endogenous EGFP expression, mainly in glomerular MCs. Furthermore, RNAi targeting against TGF-β1 significantly suppressed TGF-β1 mRNA and protein expression, thereby ameliorated the progression of matrix expansion in experimental glomerulonephritis. In addition, vector-based RNAi also inhibited TGF-β1 expression in vitro and in vivo. In conclusion, siRNA-directed TGF-β1 silencing may be of therapeutic value in the prevention and treatment of fibrotic diseases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Fire A et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806–811.

    Article  CAS  PubMed  Google Scholar 

  2. Hannon GJ . RNA interference. Nature 2002; 418: 244–251.

    Article  CAS  PubMed  Google Scholar 

  3. Billy E et al. Specific interference with gene expression induced by long, double-stranded RNA in mouse embryonal teratocarcinoma cell lines. Proc Natl Acad Sci USA 2001; 98: 14428–14433.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Elbashir SM et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494–498.

    Article  CAS  PubMed  Google Scholar 

  5. Tsujie M et al. Electroporation-mediated gene transfer that targets glomeruli. J Am Soc Nephrol 2001; 12: 949–954.

    CAS  PubMed  Google Scholar 

  6. Border W, Noble N . Transforming growth factor in tissue fibrosis. N Engl J Med 1994; 331: 1286–1292.

    Article  CAS  PubMed  Google Scholar 

  7. Noah DL, Blum MA, Sherry B . Transfection of primary cardiac myocyte cultures with DNA and anti-sense oligonucleotides using FuGENE 6 transfection reagent. Biochemica 1998; 2: 38–40.

    Google Scholar 

  8. Ito T et al. Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling. J Am Soc Nephrol 2001; 12: 2625–2635.

    CAS  PubMed  Google Scholar 

  9. McCaffrey AP et al. RNA interference in adult mice. Nature 2002; 418: 38–39.

    Article  CAS  PubMed  Google Scholar 

  10. Song E et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003; 9: 347–351.

    Article  CAS  PubMed  Google Scholar 

  11. Xia H, Mao Q, Paulson HL, Davidson BL . siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol 2002; 20: 1006–1010.

    Article  CAS  PubMed  Google Scholar 

  12. Valdes VJ, Sampieri A, Sepulveda J, Vaca L . Using double-stranded RNA to prevent in vitro and in vivo viral infections by recombinant baculovirus. J Biol Chem 2003; 278: 19317–19324.

    Article  CAS  PubMed  Google Scholar 

  13. Border WA et al. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 1990; 346: 371–374.

    Article  CAS  PubMed  Google Scholar 

  14. Bridge AJ et al. Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 2003; 34: 263–264.

    Article  CAS  PubMed  Google Scholar 

  15. Sledz CA et al. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 2003; 5: 834–839.

    Article  CAS  PubMed  Google Scholar 

  16. Kennedy S, Wang D, Ruvkun G . A conserved siRNA-degrading RNase negatively regulates RNA interference in C. elegans. Nature 2004; 427: 645–649.

    Article  CAS  PubMed  Google Scholar 

  17. Sugiura T et al. Group II phospholipase A2 activates mitogen-activated protein kinase in cultured rat mesangial cells. FEBS Lett 1995; 370: 141–145.

    Article  CAS  PubMed  Google Scholar 

  18. Kawachi H et al. Epitope-specific induction of mesangial lesions with proteinuria by a MoAb against mesangial cell surface antigen. Clin Exp Immunol 1992; 88: 399–404.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Novina CD et al. siRNA-directed inhibition of HIV-1 infection. Nat Med 2002; 8: 681–686.

    Article  CAS  PubMed  Google Scholar 

  20. Akagi Y et al. Inhibition of TGF-beta1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 1996; 50: 148–155.

    Article  CAS  PubMed  Google Scholar 

  21. Nakamura H et al. Introduction of DNA enzyme for Egr-1 into tubulointerstitial fibroblasts by electroporation reduced interstitial alpha-smooth muscle actin expression and fibrosis in unilateral ureteral obstruction (UUO) rats. Gene Therapy 2002; 9: 495–502.

    Article  CAS  PubMed  Google Scholar 

  22. Daniel C et al. Antisense oligonucleotides against thrombospondin-1 inhibit activation of TGF-beta in fibrotic renal disease in the rat in vivo. Am J Pathol 2003; 163: 1185–1192.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takabatake, Y., Isaka, Y., Mizui, M. et al. Exploring RNA interference as a therapeutic strategy for renal disease. Gene Ther 12, 965–973 (2005). https://doi.org/10.1038/sj.gt.3302480

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302480

Keywords

This article is cited by

Search

Quick links